Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06655779Not Yet Recruiting

Performance of the Acoustic Based CADScor System in Coronary Artery Disease

Role: lead

NCT04057404Completed

Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction

Role: lead

NCT02248974Not ApplicableCompleted

Development & Testing of a Decision Aid for LVAD Placement

Role: collaborator

NCT00179491Phase 3Completed

Study of the Therapeutic Effects of Intercessory Prayer (STEP)

Role: collaborator

All 4 trials loaded